Hims & Hers Shares Slip After Q2 Loss, Regulatory Scrutiny Persists

Shares of Hims & Hers Health (NYSE: HIMS) slipped roughly 3% on Tuesday, a sharp after‑hours decline that followed a 7...

Read story →

Undercovered Dozen Highlights: High-Yield Blue Owl, IBMs Quantum Deal, and Hims & Hers Novo Nordisk Partnership

The weekly Undercovered Dozen series from Seeking Alpha spotlights twelve lesser‑covered stocks that have attracted re...

Read story →